Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Jan SkupienAdam M SmilesErkka ValoTarunveer S AhluwaliaBeata GyorgyErkka ValoStephanie CroallMaria LajerKevin McDonnellCarol ForsblomJoanne B ColeMichel MarreAndrzej T GaleckiDavid-Alexandre TregouetChun Yi WuJosyf C MychaleckyjHelen NickersonMarlon PragnellStephen S RichMarcus G Pezzolesi Samy HadjadjPeter RossingPer-Henrik Groop Andrzej S Krolewski

Published in: Diabetes care (2018)

Despite almost universal renoprotective treatment, progression to ESRD and mortality in patients with type 1 diabetes with advanced nephropathy are still very high and differ among countries. Finding causes of these differences may help reduce risk of these outcomes.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
cardiovascular events
risk factors
type diabetes
skeletal muscle
combination therapy
metabolic syndrome
glycemic control
smoking cessation